By Megan Redshaw
VAERS data released today by the Centers for Disease Control and Prevention included a total of 927,740 reports of adverse events from all age groups following COVID vaccines, including 19,532 deaths and 146,720 serious injuries between Dec. 14, 2020, and Nov. 26, 2021.
The Centers for Disease Control and Prevention today released new data showing a total of 927,740 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and Nov. 26, 2021, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 19,532 reports of deaths — an increase of 283 over the previous week — and 146,720 reports of serious injuries, including deaths, during the same time period — up 3,325 compared with the previous week.
Foreign reports are reports received by U.S. manufacturers from their foreign subsidiaries. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 8,986 U.S. deaths reported as of Nov. 26, 20% occurred within 24 hours of vaccination, 26% occurred within 48 hours of vaccination and 61% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 454 million COVID vaccine doses had been administered as of Nov. 24. This includes 264 million doses of Pfizer, 173 million doses of Moderna and 16 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to Nov. 26, 2021 for 5- to 11-year-olds show:
- 2,586 adverse events, including 34 rated as serious and 2 reported deaths. One death occurred in an 11-year-old girl from Georgia vaccinated Sept. 14, prior to the authorization of Pfizer’s COVID vaccine in the 5 to 11 age group.
The second death (VAERS I.D. 1890705) occurred in a 5-year-old girl who died four days after receiving her first dose of Pfizer.
- 1,581 adverse events have been reported in the 5 to 11 age group since Nov. 1.
U.S. VAERS data from Dec. 14, 2020, to Nov. 26, 2021 for 12- to 17-year-olds show:
The most recent death involves a 16-year-old girl from Georgia (VAERS I.D. 1865389) who died reportedly from a heart condition and multi-organ failure two days after receiving Pfizer’s COVID vaccine.
- 60 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases
attributed to Pfizer’s vaccine.
- 563 reports of myocarditis and pericarditis (heart inflammation) with 553 cases attributed to Pfizer’s vaccine.
- 139 reports of blood clotting disorders, with all cases attributed to Pfizer.